Skip to main content

Lindsay Anne Magura Rein

Associate Professor of Medicine
Medicine, Hematologic Malignancies and Cellular Therapy
Dept of Medicine, BOX_31079 DUMC, Durham, NC 27710

Current Duke Appointments & Affiliations


Associate Professor of Medicine · 2024 - Present Medicine, Hematologic Malignancies and Cellular Therapy, Medicine
Member of the Duke Cancer Institute · 2016 - Present Duke Cancer Institute, Institutes and Centers

Recent Scholarly Works


Mastocytosis: Part I: Pathogenesis, clinical presentation, and classification.

Journal article J Am Acad Dermatol · November 2026 Mast cells are tissue-resident immune cells which secrete numerous and varied immune mediators in response to a myriad of activation pathways and play an important physiological function in immunity, homeostasis, tissue repair, and nervous system regulatio ... Full text Link to item Cite

Mastocytosis: Part II: Diagnosis and management of mastocytosis through a multidisciplinary lens.

Journal article J Am Acad Dermatol · November 2026 Mastocytosis is a heterogeneous disorder marked by mast cell accumulation in various organs, presenting differently in children and adults. Red or brown maculopapular lesions on the skin should raise suspicion for mastocytosis. In children, presentations i ... Full text Link to item Cite

VERIFY: A Phase III Trial of Rusfertide Versus Placebo in Phlebotomy-Dependent Patients With Polycythemia Vera Receiving Standard-of-Care Therapy.

Journal article J Clin Oncol · October 13, 2026 PURPOSE: Polycythemia vera (PV) is a myeloproliferative neoplasm characterized by erythrocytosis. Rusfertide is a subcutaneous, injectable, hepcidin mimetic peptide that suppresses erythrocytosis. The phase III VERIFY trial evaluated the efficacy and safet ... Full text Link to item Cite
View All Scholarly Works

Education


University of North Dakota, School of Medicine and Health Sciences ยท 2008 M.D.